Shanghai Junshi Biosciences Co., Ltd. released its monthly return for the period ended 30 November 2025. The total registered capital remained RMB 1,026,689,871, which includes 260,295,700 H shares (listed on the Hong Kong Stock Exchange under stock code 01877) and 766,394,171 A shares (listed on the STAR Market of the Shanghai Stock Exchange under stock code 688180). No changes were recorded in the number of issued H shares or A shares during the reporting period.

According to the disclosure, the H Share Option Incentive Scheme reported 13,210,000 share options outstanding at the start and end of November 2025, with no adjustments. Under the A Share Option Incentive Scheme, 450,000 share options were canceled during the month, reducing the outstanding total from 25,150,000 to 24,700,000. There were no share issuances, treasury share movements, warrants, or convertible securities during this period.

As stated in the filing, all relevant procedures, including those required by Hong Kong and mainland regulatory authorities, were completed in compliance with the respective rules and regulations. The company remains in full compliance with applicable listing and disclosure requirements.